ClinicalTrials.gg
Sign In

Lymphoma, B-Cell, Marginal Zone clinical trials

The registry lists 875 studies for Lymphoma, B-Cell, Marginal Zone across more than 10 countries. 111 are recruiting or about to start. 133 of them are mainly about Lymphoma, B-Cell, Marginal Zone (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 920 studies for Lymphoma, B-Cell, Marginal Zone. How that becomes 875 here

This page counts the studies the registry files under Lymphoma, B-Cell, Marginal Zone, and those it files under no condition that list Lymphoma, B-Cell, Marginal Zonethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 920Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −4List Lymphoma, B-Cell, Marginal Zone as a condition, but the registry did not file them under itMost often written as “Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive” (1), “Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma” (1), and “Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue” (1). The registry filed them under other conditions only, most often Stomach Neoplasms (1) and Orbital lymphoma (1).
  3. −41Match it another way5 name it in the title, 2 in a keyword, and 34 by a synonym or other text the search reads.
  4. 875The count on this page10 of them list Lymphoma, B-Cell, Marginal Zone in their own words; the registry filed them under no condition.

Get an email when these change. Save the Lymphoma, B-Cell, Marginal Zone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
496
Terminated
124
Recruiting
92
Active, not recruiting
54
Status unknown
48
Withdrawn
41

Phase

Phase 2
397
Phase 1
364
Phase 3
71
Early Phase 1
6
Phase 4
3

Where

United States
674
Italy
62
China
58
France
58
Germany
45
United Kingdom
43

Who runs them

National Cancer Institute (NCI) (80) · Fred Hutchinson Cancer Center (56) · Memorial Sloan Kettering Cancer Center (28) · City of Hope Medical Center (25) · Masonic Cancer Center, University of Minnesota (24) · Mayo Clinic (24) · Case Comprehensive Cancer Center (19) · Roswell Park Cancer Institute (15)

What is being tested here

Drugs under test in Lymphoma, B-Cell, Marginal Zone studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Orelabrutinib15119
Rituximab910101
Lenalidomide5230
Obinutuzumab4010
Fludarabine3363
Venetoclax3012
Pirtobrutinib306
Epcoritamab305
Mosunetuzumab314
Cyclophosphamide2466

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 26 open · Antimetabolites 4 open · Alkylating agents 3 open · Antibody-drug conjugates (ADCs) 2 open · Calcineurin inhibitors 36

Coming up

10phase 3 studies under way
47studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 92 Lymphoma, B-Cell, Marginal Zone studies recruiting now, 77 (84%) set no upper age limit and 7 (8%) stop at 75 or younger. 9 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (3%) take healthy volunteers.

Recruiting studies that take each age, of 92
AgeWomenMen
106 (7%)6 (7%)
1890 (98%)90 (98%)
3091 (99%)91 (99%)
4091 (99%)91 (99%)
5091 (99%)91 (99%)
6591 (99%)91 (99%)
7590 (98%)90 (98%)
8581 (88%)81 (88%)

Across all 875 studies, recruiting or not: 19% stop at 75 or younger and 9% at 65; 22% take children; 0% are for women only and <1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lymphoma, B-Cell, Marginal Zone studies take

Of 113 phase 2 interventional studies under Lymphoma, B-Cell, Marginal Zone, half reached primary completion within 69 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 157 mo38–102 · 81 studies—64 mo43–108 · 46 studies
Phase 1/278 mo49–114 · 38 studies——
Phase 269 mo38–110 · 113 studies—73 mo42–117 · 97 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 875. Browse all 875 → or search them.